Catalyst Wire Dossier Catalyst Wire Dossier

Vesanoid

all-trans retinoic acid · Eisai Co., Ltd.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Vesanoid, covering 2016-01-29 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia [Phase 2]

See pricing